Sartaj Tabassum

Aligarh Muslim University — India

Medicine · Health Sciences

42h-index5.5kcitations279works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metal complexes synthesis and properties(152), Crystallization and Solubility Studies(67), X-ray Diffraction in Crystallography(67), Synthesis and Characterization of Heterocyclic Compounds(34), Ferrocene Chemistry and Applications(32)

Publications279 total

Unravelling the structural insights and in vitro biomolecular interactions of new bioactive copper(II) based chemotherapeutic agents by spectroscopic and computational methods
Polyhedron·2025· 1 cited
Real-Time Dermatological Classification and Knowledge Retrieval: A Deep Learning and Web Scraping Approach
2025
Synthesis and structure elucidation of tailored metal-based intercalative agents derived from anthraldehyde & L-valine that show selective inhibition against triple-negative resistant breast cancer cells
Polyhedron·2025· 1 cited
Synthesis, spectroscopic, single crystal X-ray diffraction studies of Bilastine, BLA(bpy)2Cu(II) & Zn(II) complexes as anticancer chemotherapeutic agents: Validation of their cytotoxic potency on cancer cell lines
Journal of Molecular Structure·2024· 1 cited
Multilingual Approaches to Named Entity Recognition
2024· 2 cited
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
Drug Discovery Today·2024· 29 cited
De novo design and preparation, structural details, and cytotoxic response of a new water soluble (2,2′–bipy)–(phenylalaninato)–μ–chlorido–copper(II) drug candidate against resistant cancer cells
Journal of Molecular Structure·2024· 2 cited
De novo design and preparation of Copper(II)–based chemotherapeutic anticancer drug candidates with Boc–glycine and N,N–donor ligands: DNA binding, cleavage profile, and cytotoxic therapeutic response against MCF–7, PC–3, and HCT–116 cells
Polyhedron·2024· 10 cited
Classification of Metal-Based Anticancer Chemotherapeutic Agents
2024
DNA Condensation Processes Mediated by Metal-Based Drug Entities and Morphological Studies
2024
Introduction
2024
Endoplasmic Reticulum (ER)-Targeted Metal-Based Anticancer Chemotherapeutic Agents
2024· 2 cited
Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets
2024· 1 cited
Molecular Docking and Computational In Silico Investigations of Metal-Based Drug Agents
2024· 2 cited
Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
2024· 3 citedOpen Access
Biophysical and Spectroscopic Techniques to Validate the Interaction with Therapeutic Targets
2024
Advanced Drug Delivery Strategies for Metal-Based Anticancer Drugs
2024
Conclusions
2024
Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency
2024
Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(<scp>ii</scp>), Cu(<scp>ii</scp>) and Zn(<scp>ii</scp>)] tailored anticancer chemotherapeutic agents against resistant cancer cells
Dalton Transactions·2024· 7 cited
page 1 of 14Next →

Frequent Co-authors

Farukh Arjmand(35), Mohd Afzal(11), Rais Ahmad Khan(11), Mehvash Zaki(8), Claudio Pettinari(7), Imtiyaz Yousuf(6), Musheer Ahmad(6), Ali Alsalme(5), F. Marchetti(4), Siffeen Zehra(4), Mohammad Usman(4), Ameer Azam(3), Waddhaah M. Al–Asbahy(3), Masrat Bashir(3), Ahmad Asim(3), Vivek Bagchi(3), Sabiha Parveen(3), Saurabh Srivastav(3), Saripella Srikrishna(3), Arham S. Ahmed(2)